| Literature DB >> 28241453 |
Xiaonan Hou1, Xiaowei Zhao2, Yamei Zhang3, Aiying Han4, Shuying Huo5, Shigang Shen6.
Abstract
Some peptide-based drugs, including oxytocin, vasopressin, ziconotide, pramlintide, nesiritide, and octreotide, contain one intramolecular disulfide bond. A novel and reusable monodispersed silica nanosphere-supported Pt(IV) complex (SiO₂@TPEA@Pt(IV)); TPEA: N-[3-(trimethoxysilyl)propyl]ethylenediamine) was synthesized via a four-step procedure and was used for the formation of intramolecular disulfide bonds in peptides. Transmission electron microscopy (TEM) and chemical mapping results for the Pt(II) intermediates and for SiO₂@TPEA@Pt(IV) show that the silica nanospheres possess a monodisperse spherical structure and contain uniformly-distributed Si, O, C, N, Cl, and Pt. The valence state of Pt on the silica nanospheres was characterized by X-ray photoelectron spectroscopy (XPS). The Pt(IV) loaded on SiO₂@TPEA@Pt(IV) was 0.15 mmol/g, as determined by UV-VIS spectrometry. The formation of intramolecular disulfides in six dithiol-containing peptides of variable lengths by the use of SiO₂@TPEA@Pt(IV) was investigated, and the relative oxidation yields were determined by high-performance liquid chromatography (HPLC). In addition, peptide 1 (Ac-CPFC-NH₂) was utilized to study the reusability of SiO₂@TPEA@Pt(IV). No significant decrease in the relative oxidation yield was observed after ten reaction cycles. Moreover, the structure of SiO₂@TPEA@Pt(IV) after being used for ten cycles was determined to be similar to its initial one, demonstrating the cycling stability of the complex.Entities:
Keywords: intramolecular disulfide; monodisperse silica nanospheres; peptide; reusability; supported platinum(IV) complex
Mesh:
Substances:
Year: 2017 PMID: 28241453 PMCID: PMC6155793 DOI: 10.3390/molecules22020338
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1A schematic route for the synthesis of SiO2@TPEA@Pt(IV). TPEA: N-[3-(trimethoxysilyl)propyl]ethylenediamine.
Figure 1(a) TEM image and elemental mapping of SiO2@TPEA@PtCl2; (b) TEM image of SiO2@TPEA@Pt(II); (c) TEM image and energy dispersive X-ray spectroscopy (EDX) data for SiO2@TPEA@Pt(IV).
Figure 2High resolution Pt 4f X-ray photoelectron spectroscopy (XPS) spectra of (a) Pt(en)2Cl2; (b) [Pt(en)2Cl2]Cl2; (c) SiO2@TPEA@Pt(II); (d) SiO2@TPEA@Pt(II) generated from the peptide 1 reduction of SiO2@TPEA@Pt(IV); and (e) SiO2@TPEA@Pt(IV).
The sequences of dithiol-containing peptides and the relative oxidation yields.
| Peptide Sequence | Relative Oxidation Yield |
|---|---|
| 1 Ac-CPFC-NH2 | 84% |
| 2 CGYCHKLHQMK-NH2 | 68% |
| 3 CYFQNCPRG-NH2 (reduced arginine vasopressin) | 68% |
| 4 CRGDKGPDC-NH2 (reduced iRGD peptide) | 50% |
| 5 CYINQCPLG-NH2 (reduced oxytocin) | 59% |
| 6 AGCKNFFWKTFTSC (reduced somatostatin) | 50% |
Figure 3HPLC chromatograms of (a) peptide 1 (1.0 mg/mL, 1.5 mL) after stirring for 30 min; (b) the supernatant from the reaction of SiO2@TPEA@Pt(IV) (50 mg) with peptide 1 (1.0 mg/mL, 1.5 mL) for 30 min; and (c) the mixture from the reaction of [Pt(en)2Cl2]Cl2 (1.8 mg) with peptide 1 (1.0 mg/mL, 1.5 mL).
Scheme 2Proposed mechanism for disulfide formation in peptide 1 by SiO2@TPEA@Pt(IV).
Figure 4Reusability of SiO2@TPEA@Pt(IV) over ten reaction cycles.
Figure 5SEM images of SiO2@TPEA@Pt(IV) before (left) and after (right) being used for ten cycles.